Mode
Text Size
Log in / Sign up

Huayu Xiaozheng Decoction added to triptorelin and mifepristone for uterine fibroids in 102 womenA New Fibroid Treatment Combo Shows Promise—With Fewer Side Effects

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider HYXZD combination therapy findings preliminary; recurrence benefit was not significant.

This randomized controlled trial enrolled 102 women with uterine fibroids. The observation group received Huayu Xiaozheng Decoction (HYXZD) combined with triptorelin and mifepristone, while the control group received only triptorelin plus mifepristone. The study followed participants for 12 months.

The group receiving the HYXZD combination showed a higher total effective rate (P < 0.05). Greater reductions in menstrual flow, fibroid volume, sex hormone levels (LH, E, FSH), hemorheologic parameters (BVH, BVL, PAGT), and serum tumor markers (CA125, CEA) were observed in the HYXZD group (all P < 0.05). Improvements in uterine artery hemodynamics (PI, RI, S/D) were also better in the observation group (P < 0.05). The 1-year recurrence rate was 7.84% (4/51) in the HYXZD group versus 11.76% (6/51) in the control group, a difference that was not statistically significant (P = 0.505).

Safety data indicated a lower adverse reaction rate in the observation group receiving the HYXZD combination. Key limitations include the lack of reported effect sizes and confidence intervals for most outcomes. The composition, standardization, and dosing of the herbal decoction (HYXZD) were not described. The clinical relevance is restrained to this specific population and regimen, and the non-significant recurrence rate difference tempers conclusions about long-term benefit.

Imagine planning your life around your period. For millions of women with uterine fibroids, this is a monthly reality. The heavy bleeding, cramping, and pressure aren't just inconvenient. They're debilitating.

Now, a new study points to a potential way to fight back more effectively. And it involves blending modern medicine with ancient wisdom.

Uterine fibroids are incredibly common. Up to 80% of women will develop them by age 50.

These non-cancerous growths in the uterus can cause severe pain, anemia from blood loss, and fertility issues. For many, the journey to relief is frustrating. Treatments range from monitoring to surgery.

Hormone-blocking drugs, like the ones in this study, are a common option. They can shrink fibroids. But they often come with side effects that feel like a trade-off.

The Surprising Shift

The standard approach has been to use drugs that lower hormone levels. This starves the fibroids, making them shrink.

But here's the twist. What if you could attack the problem from another angle at the same time?

Researchers in China tested a combination therapy. One group received two standard hormone-blocking drugs. The other group received those same two drugs plus an herbal formula called Huayu Xiaozheng Decoction (HYXZD).

This formula has been used in Traditional Chinese Medicine for centuries to address masses and poor blood flow.

Think of a fibroid like a weed in a garden. The standard drugs work by turning off the "sprinkler system" of hormones that feed it.

The herbal formula may work on the soil and the roots. It's designed to improve blood flow and reduce what practitioners call "blood stasis" and "phlegm dampness." In modern terms, this likely means reducing inflammation and improving circulation in the uterus.

By combining these approaches, the treatment doesn't just starve the weed. It may also make the environment less hospitable for it to grow back.

A Snapshot of the Study

The study involved 102 women with uterine fibroids. They were split into two groups and treated for three months. One group got the two-drug combo. The other got the two drugs plus the herbal decoction.

Scientists then tracked everything from fibroid size and blood loss to hormone levels and markers of inflammation.

The results were clear. The group taking the herbal-drug combo saw better outcomes across the board.

Their fibroids shrank more. Their menstrual bleeding decreased more significantly. Their hormone levels improved more favorably. Even key markers of inflammation and tumor growth in the blood dropped lower.

Perhaps most importantly, the side effect rate was significantly lower in the group taking the herbal addition.

But Here's the Catch

This doesn't mean this herbal formula is available at your local pharmacy.

After one year, the recurrence rate was lower in the combo group, but the difference wasn't large enough to be statistically certain. This suggests the combo might help fibroids stay away longer, but a larger, longer study is needed to prove it.

While this is a single study, it adds to a growing body of research on integrative medicine. The idea is to combine the best of different healing traditions to improve patient outcomes and reduce the downsides of treatment.

The significant reduction in side effects is a finding that particularly grabs attention. It suggests the herbal addition might help protect the body from the harsh effects of strong hormone-blocking drugs.

This research is promising, but it is still in the early stages. The herbal formula used is a specific prescription from a Traditional Chinese Medicine practitioner, not an over-the-counter supplement.

If you are struggling with fibroid management, do not start any new herbs without consulting your doctor. Some can interact with medications.

Your best step is to have an informed conversation. You could ask your gynecologist, "I read about research combining drugs with herbal medicine for fibroids. What are your thoughts on integrative approaches for my care?"

Understanding the Limits

This study was relatively small and took place in a specific setting. The herbal decoction was given as a liquid formula, and quality control can vary. We also don't know the long-term effects beyond one year.

More research is needed to confirm these results in larger, more diverse groups of women.

The next steps involve larger clinical trials, potentially in other countries. Researchers need to pinpoint exactly how the herbs are working on a biological level.

The path from research to a widely accepted treatment protocol is long. It requires rigorous testing for safety, consistency, and effectiveness. For now, this study offers a compelling glimpse into a future where treatment could be more effective and gentler.

Would you consider discussing an integrative approach like this with your healthcare team?

6. SEO BOOST (Internal Linking)

Non-surgical treatments for uterine fibroids What to know about hormone therapy for women's health How to talk to your doctor about alternative medicine

Study Details

Study typeRct
EvidenceLevel 2
Follow-up12.0 mo
PublishedApr 2026
View Original Abstract ↓
OBJECTIVE: To expound the efficacy of Huayu Xiaozheng Decoction (HYXZD) combined with triptorelin and mifepristone in the treatment of uterine fibroids, with a particular focus on its effect on uterine artery hemodynamics. METHODS: A total of 102 women with uterine fibroids were enrolled and randomly allocated into a control group and an observation group. The control group received triptorelin plus mifepristone, while the observation group was additionally treated with HYXZD. Both groups were treated for 3 months. Clinical efficacy was compared, and the following parameters were measured before and after treatment: menstrual flow, fibroid volume, sex hormone levels (LH, E, FSH), uterine artery hemodynamics (PI, RI, S/D), hemorheologic parameters (BVH/BVL, PAGT), serum tumor markers (CA125, CEA), adverse reactions, and 1-year recurrence rate. RESULTS: The total effective rate was higher in the observation group relative to the control group (P < 0.05). Before treatment, no notable differences existed between groups in menstrual flow, fibroid volume, LH, E, FSH, PI, RI, S/D, BVH, BVL, PAGT, CA125, or CEA (P > 0.05). Following treatment, both groups showed reductions in menstrual flow, fibroid volume, LH, E, FSH, BVH, BVL, PAGT, CA125, and CEA, with greater reductions in the observation group (P < 0.05); PI, RI, and S/D increased in both groups, with better improvements in the observation group (P < 0.05). The adverse reaction rate was lower in the observation group versus the control group (P = 0.013). At the 1-year follow up, recurrence occurred in 11.76% (6/51) of patients in the control group and 7.84% (4/51) of patients in the observation group (P = 0.505). CONCLUSION: HYXZD combined with triptorelin and mifepristone improves clinical outcomes in uterine fibroid treatment by reducing fibroid size, optimizing hormone levels and hemodynamics, lowering tumor markers, and maintaining safety.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.